Department of Diagnostic and Interventional Radiology.
Department of Cardiology and Angiology.
Medicine (Baltimore). 2021 Jan 15;100(2):e24254. doi: 10.1097/MD.0000000000024254.
Carbon dioxide (CO2) gas is an established alternative to iodine contrast during angiography in patients with risk of postcontrast acute kidney injury and in those with history of iodine contrast allergy. Different CO2 delivery systems during angiography are reported in literature, with automated delivery system being the latest. The aim of this study is to evaluate the safety, efficacy, and learning curve of an automated CO2 injection system with controlled pressures in peripheral arterial interventions and also to study the patients' tolerance to the system.From January 2018 to October 2019 peripheral arterial interventions were performed in 40 patients (median age-78 years, interquartile range: 69-84 years) using an automated CO2 injection system with customized protocols, with conventional iodine contrast agent used only as a bailout option. The pain and tolerance during the CO2 angiography were evaluated with a visual analog scale at the end of each procedure. The amount of CO2, iodine contrast used, and radiation dose area product for the interventions were also systematically recorded for all procedures. These values were statistically compared in 2 groups, viz first 20 patients where a learning curve was expected vs the rest 20 patients.All procedures were successfully completed without complications. All patients tolerated the CO2 angiography with a median total pain score of 3 (interquartile range: 3-4), with no statistical difference between the groups (P = .529). The 2 groups were statistically comparable in terms of comorbidities and the type of procedures performed (P = .807). The amount of iodine contrast agent used (24.60 ± 6.44 ml vs 32.70 ± 8.70 ml, P = .006) and the radiation dose area product associated were significantly lower in the second group (2160.74 ± 1181.52 μGym2 vs 1531.62 ± 536.47 μGym2, P = .043).Automated CO2 angiography is technically feasible and safe for peripheral arterial interventions and is well tolerated by the patients. With the interventionalist becoming familiar with the technique, better diagnostic accuracy could be obtained using lower volumes of conventional iodine contrast agents and reduction of the radiation dose involved.
二氧化碳(CO2)气体是一种已被证实的碘对比剂替代品,适用于有发生碘对比剂急性肾损伤风险的患者,以及有碘对比剂过敏史的患者。文献中报道了不同的 CO2 输送系统,其中自动化输送系统是最新的。本研究旨在评估一种自动化 CO2 注射系统在周围动脉介入治疗中的安全性、有效性和学习曲线,同时研究患者对该系统的耐受性。
从 2018 年 1 月至 2019 年 10 月,我们对 40 例患者(中位年龄 78 岁,四分位距 69-84 岁)进行了周围动脉介入治疗,使用了一种带有定制方案的自动化 CO2 注射系统,仅将常规碘对比剂作为备用选择。在每次手术结束时,使用视觉模拟量表评估 CO2 血管造影期间的疼痛和耐受性。还系统性地记录了所有手术中 CO2、碘对比剂的用量和辐射剂量面积产品。这些值在 2 个组之间进行了统计学比较,即预计会有学习曲线的前 20 例患者与其余 20 例患者。
所有手术均顺利完成,无并发症。所有患者均耐受 CO2 血管造影,中位总疼痛评分为 3 分(四分位距 3-4 分),2 组之间无统计学差异(P=0.529)。2 组在合并症和手术类型方面具有统计学可比性(P=0.807)。第 2 组中使用的碘对比剂的量(24.60±6.44ml 比 32.70±8.70ml,P=0.006)和相关的辐射剂量面积产品明显较低(2160.74±1181.52μGym2 比 1531.62±536.47μGym2,P=0.043)。
自动化 CO2 血管造影对于周围动脉介入治疗来说是可行且安全的,患者耐受性良好。随着介入医生对该技术的熟悉,使用较低剂量的常规碘对比剂和降低相关辐射剂量,可以获得更好的诊断准确性。